MagnisDx NGS Prep System
CE-IVD
The MagnisDx system provides a complete workflow for NGS library preparation that is fully automated and delivers reproducible results. Built on proven Agilent SureSelect XT HS2 chemistry, start from total RNA with integrated cDNA conversion or unfragmented DNA with onboard enzymatic fragmentation for increased workflow efficiency.
This new bench-top instrument self-detects and tunes; the reagents come pre-aliquoted; and pre-set protocols are included.
The system requires minimal expertise to run. The onboard wizard allows assays to be set up in under five minutes. In addition, the Magnis notifies users of correct reagent placement through automated barcode checking. Upon pressing the start button, the user can walk away from the instrument, yet visually check progress through the wizard and the LED status indicator.
This new bench-top instrument self-detects and tunes; the reagents come pre-aliquoted; and pre-set protocols are included.
The system requires minimal expertise to run. The onboard wizard allows assays to be set up in under five minutes. In addition, the Magnis notifies users of correct reagent placement through automated barcode checking. Upon pressing the start button, the user can walk away from the instrument, yet visually check progress through the wizard and the LED status indicator.
For In Vitro Diagnostic Use.
Product Details
Features
- MagnisDx works seamlessly with Agilent’s industry-leading SureSelect target enrichment system and delivers sequencing data that are robust, traceable, and reproducible
- This benchtop instrument self-detects and tunes; the reagents are provided pre-aliquoted; and the system comes with pre-set protocols for Agilent’s catalog and custom assays.
- The LED status indicator will light up green allowing you to
monitor status easily from a distance. - When combined with the Agilent 4150 TapeStation System, the system provides quality control of the sample throughout the workflow.
Featured References
- Publications
-
- Martinez-Gutierrez, L. N.; Burgher, B. C.; Glynias, M. J.; Alvarado, D.; Griffiths, E. A.; Glenn, S. T.; Sung, P. J. Evaluation of Hypereosinophilia in a Case of FLT3-Mutant Acute Myeloid Leukemia Treated with Gilteritinib. Molecular Case Studies 2023, 9 (3), a006279.
Learn More - Callens, C.; Rodrigues, M.; Briaux, A.; Frouin, E.; Eeckhoutte, A.; Pujade-Lauraine, E.; Renault, V.; Stoppa-Lyonnet, D.; Bieche, I.; Bataillon, G.; Karayan-Tapon, L.; Rochelle, T.; Heitz, F.; Cecere, S. C.; Pérez, M. J. R.; Grimm, C.; Nøttrup, T. J.; Colombo, N.; Vergote, I.; Yonemori, K. Shallow Whole Genome Sequencing Approach to Detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 Phase-III Trial. Oncogene 2023, 42 (48), 3556–3563. Learn More
- Gargallo, P.; Molero, M.; Bilbao, C.; Stuckey, R.; Carrillo‐Cruz, E.; Hermosín, L.; Pérez‐López, O.; Jiménez-Velasco, A.; Soria, E.; Marián Lázaro; Carbonell, P.; Yania Yáñez; Isabel Neira Gómez; Izquierdo-García, M.; Valero-García, J.; Carlos Alberto Ruíz; Such, E.; Calabria, I. Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology. Cancers 2022, 14 (8), 1986–1986. Learn More
- Emiliani, F.; Aziz, A.; Hughes, E.; Tsongalis, G.; Zanazzi, G.; Lin, C.-C. ISCORED: Nanopore-Based Random Genomic Sampling for Intraoperative Molecular Diagnosis. medRxiv (Cold Spring Harbor Laboratory) 2023. Learn More
- Martinez-Gutierrez, L. N.; Burgher, B. C.; Glynias, M. J.; Alvarado, D.; Griffiths, E. A.; Glenn, S. T.; Sung, P. J. Evaluation of Hypereosinophilia in a Case of FLT3-Mutant Acute Myeloid Leukemia Treated with Gilteritinib. Molecular Case Studies 2023, 9 (3), a006279.
